AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging Population

September 23rd 2022, 2:51pm


The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances. Cancers related to obesity are also on the rise.

Childhood Trauma Not a Barrier to Successful Depression Treatment, Analysis Finds

September 22nd 2022, 10:30pm


Prior research has suggested that childhood trauma is linked with a poorer response to psychotherapy and prescription drug treatment for major depressive disorder, but a large meta-analysis suggested otherwise.

Moonshot 2.0 Looks to Focus on Caregivers, Learn From Patients

September 21st 2022, 2:01pm


Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.

Digital Therapeutics Face Challenges With Control Conditions in RCTs

September 10th 2022, 2:50pm


As a result of the potential of digital therapeutics to increase access to personalized care, many choose less stringent minimal control than typically seen in randomized controlled trials (RCTs).

Dr Vivienne Hau: Without Representation, Clinical Trials Cannot Adequately Judge Drug Effectiveness

September 6th 2022, 1:51pm


Different populations respond differently to drugs and treatments, but without adequate representation in clinical trials, it will be hard to judge the effectiveness of a new treatment, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.

Success in Eosinophil-Targeted Treatments for EoE Remains Limited

September 2nd 2022, 8:53pm


The researchers compiled data from studies of lirentelimab, mepolizumab, reslizumab, and benralizumab, highlighting the difficulties in finding an effective approach with eosinophil-targeted treatments for eosinophilic esophagitis (EoE).

Patients and Parents Impacted by SMA May Be Optimistic About Prenatal Testing, Therapies

September 2nd 2022, 6:15pm


As the feasibility of phase 1 clinical trials for prenatal spinal muscular atrophy (SMA) therapies is explored, patient and parent input on prenatal testing and possibly treatment is a valuable tool for guiding research discussions.

How Advocacy Groups and Patient Data Can Help Drive Health Equity

August 15th 2022, 9:15pm


Taking Action to Address Health Equity in Oncology

August 15th 2022, 8:07pm


Can Reassurance Techniques Improve Patient Confidence in Biosimilars for Psoriasis?

August 13th 2022, 3:20pm


A number of psychologic interventions were assessed to see if they could have an effect on patient confidence in biosimilars to treat psoriasis.